Abstract
Carbimazole is an antithyroid drug of the thionamide class which is used in the treatment of hyperthyroidism. Rarely, use of this drug may be associated with the development of agranulocytosis and neutropenia with the consequent risk of sepsis. We present the case of a 50-year-old female who developed rapidly progressive Pseudomonas aeruginosa septicemia in the setting of panycytopenia approximately 4 weeks following the commencement of carbimazole therapy for Graves’ disease. She died shortly after presentation to hospital and the case was referred to the coroner as the death was unexpected and the clinical course was considered unusual. Relatively sudden, unexpected deaths resulting from hematological/endocrine causes are uncommonly encountered by forensic pathologists and this case serves to illustrate the enduring value of the autopsy in providing important clinicopathological correlation to clinicians.
References
Pearce SH. Spontaneous of adverse reactions to carbimazole and propylthiouracyl in the UK. Clin Endocrinol. 2004;61(5):589–94.
Astwood EB. Chemotherapy of hyperthyroidism. Harvey Lect. 1945;40:195–235.
Coroners Act (Vic) 1985 s3
Cooper DS. Antithyroid drugs. NEJM 2005;352:905–17.
van der Klauw MM, Goudsmit R, Halie R, Veer M, Herings R, Wilson P, Stricker B. A population based case cohort study of drug associated agranulocytosis. Arch Intern Med. 1999;159(4):369–74.
Bux J, Ernst-Schlegel M, Roth B, Panzer C. Neutropenia and anaemia due to carbimazole-dependent antibodies. Br J Haematol. 2000;109(1):243–7.
Bartalena L, Bogazzi F, Martino E. Adverse effects of thyroid hormone preparations and anti thyroid drugs. Drug Saf. 1996;15(1):53–63.
Vilchez FJ, Torres I, Garcia-Valero A, Lopez-Tinoco C. Concomitant agranulocytosis and hepatotoxicity after treatment with carbimazole. Ann Pharmacother. 2006;40(11):2059–63.
Tavintharan S, Rajasoorya C, Chew LS. Carbimazole-induced agranulocytosis—a report of 2 recent cases. Singapore Med J. 1997;38(9):386–7.
Cooper DS, Goldminz D, Levin A, Ladenson P, Daniels G, Molitch M, Ridgway E. Agranulocytosis associated with anti thyroid drugs. Effects of patient age, drug dose. Ann Intern Med. 1983;98(1):26–9.
Joseph F, Younis N, Bowen-Jones D. Treatment of carbimazole induced agranulocytosis and sepsis with granulocyte colony stimulating factor. Int J Clin Pract. 2003;57(2):145–6.
Tanaka M, Tao T, Kaku K, Kaneko T. Agranulocytosis induced by macrolide antibiotics. Am J Hematol. 1995;48(2):133.
The International agranulocytosis aplastic anaemia study. Anti infective drug use in relation to the risk of agranulocytosis and aplastic anaemia. Arch Intern Med. 1989;149:1036–40.
Nawabi I, Ritz N. Agranulocytosis due to propanolol. JAMA 1973;223(12):1376–77.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lynch, M.J., Woodford, N.W.F. Fatality complicating agranulocytosis in the setting of carbimazole therapy. Forensic Sci Med Pathol 4, 246–249 (2008). https://doi.org/10.1007/s12024-008-9038-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12024-008-9038-8